Second Re-irradiation of Brain Metastases: A Review of Studies Involving Stereotactic Radiosurgery

Due to advances in the systemic and local treatment, e.g., targeted therapy, immune checkpoint inhibitors, and stereotactic radiotherapy, an increasing proportion of patients with brain metastases now survive for several years. However, long-term survival is not synonymous to permanent local control...

Descripción completa

Detalles Bibliográficos
Autores principales: Nieder, Carsten, Yobuta, Rosalba, Mannsåker, Bård
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Radiation Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373883/
https://www.ncbi.nlm.nih.gov/pubmed/30788201
http://dx.doi.org/10.7759/cureus.3712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373883/
https://www.ncbi.nlm.nih.gov/pubmed/30788201
http://dx.doi.org/10.7759/cureus.3712

Ejemplares similares